Hua Medicine Stages $110 Million Hong Kong IPO at $1.1 Billion Valuation

Life Science

EpimAb Files US/China INDs for Bispecific Cancer Antibody

Life Science

Newstrike’s Up Cannabis Inc. Receives Sales Licence Amendment from Health Canada to Commence Sales of Brantford Cultivated Product From its Niagara Facility

Cannabis, Life Science

Life Science & Technology Weekly 160 – Aurora Cannabis’ $290-million deal to buy ICC Labs fuels surge in marijuana stocks

Cannabis, Life Science

Chinese online chemist 111 looks beyond lacklustre Nasdaq debut to strong growth at wholesale unit

Life Science

Zai Lab Pays $15 Million for China Rights to Electric Field Therapy for Brain Cancer

Life Science

Shanghai Pharma Signs MOU to Develop BIOCAD’s mAb Portfolio in China

Life Science

Vivo Capital Closes Latest US-China PE Fund at $635 Million

Life Science

Trump’s EPA proposes weaker methane rules for oil and gas wells

Life Science

Introducing new solutions for needle-free injection technology

Life Science

First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody as First-line Treatment for Patients with Non-Squamous Non-Small Cell Lung Cancer

Life Science

Tianjin Tasly Out-licenses US Rights to TCM Angina Drug in $50 Million Deal

Life Science

Aurora Cannabis’ $290-million deal to buy ICC Labs fuels surge in marijuana stocks

Cannabis, Life Science

2 Bay Area Biotechs Launch IPOs Worth a Combined $200 Million

Life Science

Innovent Approved for China Trial of CD47 I-O Drug

Life Science